CY 2017 Formulary-Level Cumulative Opioid Morphine Equivalent Dose (MED) Point-of-Sale (POS) Edit
Guidance for: This memo provides information regarding the template that Part D sponsors must utilize in the submission of the CY 2017 POS edit MED information to CMS via the Health Plan Management System (HPMS).
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 21, 2016
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.